PLSE
PULSE BIOSCIENCES, INC.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$47.55
+7.02%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.31
- Revenue estimate
- $520.8K
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.36
- EPS estimate
- -$0.29
- Revenue actual
- $434.0K
- Revenue estimate
- $533.3K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +4.5%
- Revenue beats (12Q)
- 1
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $64
- PT range
- $58 – $73
- Analysts
- 5
5 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.29 | -$0.36 | Miss -22.73% | $434.0K |
| May 4, 2026 | -$0.32 | -$0.27 | Beat 15.62% | $400.0K |
| Feb 19, 2026 | -$0.32 | -$0.26 | Beat 18.75% | $264.0K |
| Nov 5, 2025 | -$0.31 | -$0.29 | Beat 6.45% | $86.0K |
| Aug 12, 2025 | -$0.26 | -$0.28 | Miss -7.69% | — |
| May 8, 2025 | — | -$0.17 | — | — |
| Mar 27, 2025 | -$0.24 | -$0.17 | Beat 29.17% | $1.7M |
| Oct 30, 2024 | -$0.24 | -$0.16 | Beat 33.33% | — |
| Aug 19, 2024 | -$0.24 | -$0.20 | Beat 17.05% | — |
| Nov 13, 2023 | -$0.24 | -$0.15 | Beat 37.50% | — |
| Aug 10, 2023 | -$0.22 | -$0.19 | Beat 13.64% | — |
| May 11, 2023 | -$0.22 | -$0.23 | Miss -4.55% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026